Classen Immunotherapies - MD Carroll, Manchester 21102

Classen Immunotherapies entered the industry of Wholesale Pharmaceutical Products in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 4242101, which describes it as a Wholesale Pharmaceutical Products. For further clarification, the SIC classifies this business under the code 5122 and described it as a Wholesale Pharmaceutical Products. The business provides service to the B2B market.

To acquire more information, please contact by calling (410) 374-3203 during business hours. You can also write to the business’ Single Location at 3637 Rockdale Road, Manchester, Maryland MD 21102. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Classen Immunotherapies
Place of Business: 3637 Rockdale Road, Manchester, MD 21102
Contact Number: (410) 374-3203
Type of Service: Wholesale Pharmaceutical Products
SIC Number: 5122
NAICS Number: 4242101
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2011
Income/Year: $5.000.000 to $9.999.999
Laborers: 1 to 4
Share This Company:

Classen Immunotherapies is a company operating from Carroll, Maryland providing professional Wholesale Pharmaceutical Products and relevant B2B variables. It was founded in 2011 and registered with the SIC code 5122 as Wholesale Pharmaceutical Products, and with the NAICS code 4242101 as Wholesale Pharmaceutical Products.

With a current employee count of 1 to 4, Classen Immunotherapies has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative at (410) 374-3203 for related queries, or to locate its Single Location using the coordinates 39.668515,-76.774511.

The Single Location can also be found at the street address 3637 Rockdale Road in Manchester, Maryland 21102 and can be engaged online through the company website at , the company Twitter , and Facebook page .